ClinicalTrials.gg
Drug

Perfluorohexyloctane clinical trials

Also written Miebo and NOV03.

studies test it
13
open now
1
in phase 3
4
first study started
2018

How each study uses perfluorohexyloctane is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the perfluorohexyloctane studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
18 May 2023 · MIEBO · NDA 216675 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Brand

Miebo
4

Development codes

NOV03
4

Studies by the year they started

13 studies that test it; most in 2020 (3)

Studies that test perfluorohexyloctane, by start year
YearStudies
20181
20203
20231
20243
20253
20262

By phase

A phase 1/2 study counts in both.

Phase 2
2
Phase 3
4
Phase 4
7

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 10 · Other 3

Bausch & Lomb Incorporated (9) · Indiana University (1) · Gordon Schanzlin New Vision (1) · Novaliq GmbH (1) · Beijing Tongren Hospital (1)

Often tested with

Tested in the same studies.

Lifitegrast (2)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 1

Studies that test perfluorohexyloctane.

Studies

Open first, then newest update. How each study uses perfluorohexyloctane is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 13

Codes

What other systems call perfluorohexyloctane · ClinicalTrials.gg INT004147

  • MeSH (NLM) C118616perfluorohexyloctaneConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) 7VYX4ELWQMPERFLUOROHEXYLOCTANEConfirmed FDA, NLM, Wikidata
  • Wikidata Q81985958perfluorohexyloctaneConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C199090PerfluorohexyloctaneOne source FDA
  • DrugBank DB17823One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.